Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN106222229A reveals green enzymatic clarification for cefprozil. Achieve high purity and cost reduction in antibiotic manufacturing with scalable solutions.
Novel liquid-phase method for Eptifibatide reduces costs and improves scalability. Reliable supplier for high-purity pharmaceutical intermediates with commercial scale-up capability.
Patent CN104480181A reveals enzymatic D-7-ACA synthesis offering high purity and yield. This process enables cost reduction in pharmaceutical intermediates manufacturing and supply chain stability.
Patent CN112010801B reveals a metal-free reduction method for amlodipine base, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN103555807B reveals one-step enzymatic route for 7-ACA. Offers high purity, reduced waste, and cost-effective supply chain solutions for global buyers.
Novel DAC chromatography method ensures ICH compliant Orlistat purity with reduced solvent waste and enhanced supply chain reliability for global pharmaceutical manufacturing.
Novel recombinant E. coli route for D-HPG production offers cost reduction in API intermediate manufacturing and enhanced supply chain reliability for global pharmaceutical partners.
Patent CN102731506B reveals water-based hydrogenation for Ertapenem. Enhances purity, reduces heavy metals, and simplifies supply chain for pharmaceutical intermediates.
Novel water-based hydrogenation deprotection for ertapenem sodium improves purity and reduces heavy metals suitable for large scale industrial manufacturing operations
Patent CN105330587A details a high-yield route for 3-Acetamidophthalimide. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN102731506B reveals water-based hydrogenation deprotection improving purity and reducing heavy metals for scalable carbapenem antibiotic manufacturing supply chains.
Advanced purification method for Lipstatin improves purity and content suitable for industrial scale production and cost reduction.
Patent CN103193715A details a mild Cu-catalyzed route for 5,6-dihydropyrimidinone derivatives, offering cost reduction in API manufacturing and reliable supply chain solutions.
Novel chorismic acid pathway for NAD production. Reduces precursor costs and enhances supply chain reliability for global pharmaceutical manufacturers.
Patent CN110386942A reveals high-yield thiolactone synthesis. Offers supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN102757443A reveals a green biotransformation route for sulfur-substituted podophyllum derivatives, offering cost reduction in API manufacturing and scalable supply chains.
Patent CN114478439A details a novel post-treatment for Boc-piperazine, enabling high raw material recovery and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN107235971B reveals a new Tiamulin-based route for Retapamulin. It ensures superior quality control and reduces manufacturing costs for global supply chains significantly.
Patent CN107235971B details Retapamulin synthesis from Tiamulin. Offers better impurity control and cost reduction for API manufacturers and supply chains.
Patent CN120366799A enables green electro-reduction synthesis. Delivers high-purity pharmaceutical intermediates with significant cost reduction and supply chain reliability.